GlucoModicum publishes first-in-human data assessing the safety and effectiveness of its MHD technology for accurate needle-free glucose monitoring
Business Finland allocates significant funding to GlucoModicum
GlucoModicum completes successful pilot clinical trials
GlucoModicum completes industrial grade prototype and sensor
GlucoModicum Clinical Trial raises a lot of interest
GlucoModicum closes the next funding round
GlucoModicum has closed +1,2MEUR Seed Round
GlucoModicum closes Pre-Seed funding round
GlucoModicum Ltd is established.
GlucoModicum – Health Design 2017 Winner.